勃林格殷格翰的思力华去哪买的到？

Chronic obstructive pulmonary disease is a type of chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into common chronic diseases such as cor pulmonale and respiratory failure. It is related to the abnormal inflammatory response of harmful gases and harmful particles, and has high disability and mortality rates. It is a drug developed by Boehringer Ingelheim and has been approved for marketing in my country. Its indication is the treatment of adult chronic obstructive pulmonary disease (COPD). It can effectively improve the quality of life of COPD patients and reduce acute exacerbations of COPD.

After Boehringer Ingelheim's Slivar is approved for marketing in my country, patients can buy it in some pharmacies or hospitals in the country with a prescription issued by a doctor. The price varies in different regions and is subject to local conditions. In addition, we also learned that the price of a Slivia product is relatively low, around 170$ per box. Patients can consult the medical companion service for specific purchase methods.

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that causes shortness of breath and coughing. Spirax helps open the airways, making it easier for air to move in and out of the lungs. In vivo and in vitro studies have shown that Slihua has a dose-dependent and sustainable 24-hour inhibition of methacholine-induced bronchoconstriction. Sliva has outstanding localization selectivity in its dilation effect on bronchial tubes.

In terms of usage, the recommended dose for adults is to inhale once a day through the Respimat inhalation device at the same time, taking 2 puffs each time. Patients should not overdose. Not only is it used when experiencing breathing problems, regular use of Spirava can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life.

Recommended related hot articles: /newsDetail/88988.html